Enzflame Kids Powdered Drink Mix
On sale on the US market (according to the DSLD)
Little DaVinci, food supplement from the US market
Enzflame Kids Powdered Drink Mix (Little DaVinci), a food supplement au code-barres 026664014597, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Little DaVinci
- Barcode
- 026664014597
- Form
- Powder
- One serving
- 9 g
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Digestion-Resistant Maltodextrin, Orange, Powder, Orange Flavor, Natural, Citric Acid, Tricalcium Phosphate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 30 Calorie(s) |
| Total Carbohydrates | Carbohydrate | 8 Gram(s) |
| Dietary Fiber | Fibre | 3 Gram(s) |
| Calcium | Mineral | 40 mg |
| Cetyl Myristoleate | Fatty acid | 1,000 mg |
| Proprietary Proteolytic Enzyme Blend | Blend | 465 mg |
| Pancreatin | Blend | not stated |
| Bromelain | Enzyme | not stated |
| Papain | Enzyme | not stated |
| Pepsin | Enzyme | not stated |
| Protease | Enzyme | not stated |
| N, N-Dimethylglycine Hydrochloride | Other substance | 250 mg |
| Curcumin C3 Complex | Other substance | 200 mg |
| Curcuminoids | Other substance | 190 mg |
| Boswellia serrata Gum Extract | Plant | 200 mg |
| Boswellic Acids | Other substance | 130 mg |
| Ginger Root Extract | Plant | 50 mg |
| Gingerols | Other substance | 2.5 mg |
| Quercetin | Other substance | 75 mg |
| Rutin | Other substance | 200 mg |
| Luteolin | Other substance | 8 mg |
| Cayenne Pepper (Capsicum annuum) | Plant | 5 mg |
| Stevia Leaf Extract (Stevia rebaudiana) | Plant | 100 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Enzflame Kids Powdered Drink Mix
Entered into DSLD on 14 December 2023. Withdrawn from the US market on 27 September 2024 (according to the DSLD).- Active ingredient added : Sodium (10 mg)
- Different quantity per serving : Calories: 35 Calorie(s) in this version; 30 Calorie(s) on the displayed label
- Different quantity per serving : Proprietary Proteolytic Enzyme Blend: 930 mg in this version; 465 mg on the displayed label
Official label: Enzflame Kids Powdered Drink Mix
Entered into DSLD on 16 June 2022. Withdrawn from the US market on 1 October 2022 (according to the DSLD).- Active ingredient added : Sodium (10 mg)
- Active ingredient removed : Bromelain (quantity not stated)
- Active ingredient removed : Pancreatin (quantity not stated)
- Active ingredient removed : Papain (quantity not stated)
- Active ingredient removed : Pepsin (quantity not stated)
- Active ingredient removed : Protease (quantity not stated)
- Same quantity, different name: Boswellic Acid in this version; Boswellic Acids on the displayed label (130 mg)
- Same quantity, different name: Cayenne (Capsicum annum) Pepper in this version; Cayenne Pepper on the displayed label (5 mg)
- Same quantity, different name: Cetyl Myristoleate (CMO) Complex in this version; Cetyl Myristoleate on the displayed label (1,000 mg)
- Same quantity, different name: Ginger (Zingiber officinale) root extract in this version; Ginger Root Extract on the displayed label (50 mg)
- Same quantity, different name: N,N-Dimethylglycine HCl in this version; N, N-Dimethylglycine Hydrochloride on the displayed label (250 mg)
- Different quantity per serving : Calories: 35 Calorie(s) in this version; 30 Calorie(s) on the displayed label
- Different quantity per serving : Proprietary Proteolytic Enzyme Blend: 930 mg in this version; 465 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Rutin
Read the warning, when it applies and the studies cited
RUTIN
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).
Sources cited by Health Canada (1)
- PDR 2008: Hendler SS, Rorvik D. PDR for Nutritional Supplements. 2nd edition. Montvale (NJ): Thomson Healthcare; 2008.
- Cayenne Pepper
Read the warning, when it applies and the studies cited
CAYENNE - CAPSICUM ANNUUM Oral
Cautions and warnings
Condition of application: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
Sources cited by Health Canada (2)
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condition of application: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Cautions and warnings
Condition of application: All products.
For external use only (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Known adverse reactions
Condition of application: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
Sources cited by Health Canada (5)
- APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
- Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
- McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
- Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : Little DaVinci
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Enzflame Kids Powdered Drink Mix (Little DaVinci): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/26664014597-enzflame-kids-powdered-drink-mix-little-davinci, updated 23 February 2025.